KTTA Secures $60 Million Funding—Cash Runway Now Extends Through 2028, Backed by Top Institutional Investors
Market Chameleon (Fri, 28-Nov 9:51 AM)
KTTA Gains ALS Association Backing: $1 Million Grant Puts PAS-004 in Spotlight for ALS Therapy
Market Chameleon (Wed, 26-Nov 10:28 AM)
KTTA Reports Favorable PAS-004 Tablet PK Data: Dose-Proportional Exposure and Improved Predictability Highlighted in NF1 Trial
Market Chameleon (Mon, 24-Nov 9:53 AM)
